ATAleksei V. Tverskoi

Aleksei V. Tverskoi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Aleksei V. Tverskoi has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The use of atomic force microscopy in the comprehensive assessment of organs and tissues in diabetes mellitus

    by Irina I. Povalyaeva, Tatyana V. Pavlova, Anton N. Kaplin, Hazem Hossino, Igor Yu. Goncharov, Lyubov A. Pavlova, Maria A. Zatolokina, Alexey V. Tverskoi, Хсейно Хазем, Тверской Алексей Владимирович

    The study of biological objects using atomic force microscopy seems to be a promising direction, since it allows preserving their native structure. The use of atomic force microscopy to study nanostructural morphofunctional changes in cells of various tissues under normal conditions and pathologies can help accumulate new information about the pathogenesis of diseases, as well as become the foundation for the development of new approaches to their prevention and treatment.To study the possibilities of atomic force microscopy in studying pathomorphological changes in muscle, bone tissue and red blood cells in diabetes mellitus. The study demonstrated the possibility of using atomic force microscopy to study changes in body tissue under pathological conditions.

  • Open Access

    Influence of Dalargin on the hematological indices in mice with experimental ulcerative colitis

    by Andrey Yu. Lyashev, Galina S. Mal, Maria A. Zatolokina, Kirill D. Spiridonov, Daniil D. Spiridonov, Aleksei V. Tverskoi, Ляшев Андрей Юрьевич

    The low effectiveness of existing methods of treatment for ulcerative colitis provides the necessity of the implementation of new treatment methods. The corrective effect of dalargin has been shown in mice with ulcerative colitis, but the mechanism of drug action requires further investigation. In this regard, the study of the dalargin effect on the dynamics of hematological indices in mice with ulcerative colitis is of undoubted interest. Ulcerative colitis in mice was simulated by replacing drinking water with a 5% solution of sodium dextran sulfate for 5 days. A decrease in the Krebs index, an increase in the leukocyte index, an index of the ratio of neutrophils to monocytes and an index of the ratio of lymphocytes to monocytes under the influence of dalargin (100 mcg/kg subcutaneously for 7 days) were shown in mice with experimental ulcerative colitis on the 5th day, as well as a decrease in the index of the ratio of lymphocytes and monocytes on the 7th day. The corrective effect of dalargin on hematological indices in mice with ulcerative colitis is higher than that of sulfasalazine.

  • Open Access

    The versatility of using platelet-enriched autoplasm in medical practice

    by Tamara V. Mutova, Maria A. Zatolokina, Boris S. Sukovatykh, Viktor Ya. Mutov, Stanislav V. Gunov, Alexey V. Tverskoy, Lyudmila M. Kachmarskaya, Dmitry V. Reshetnyakov, Тверской Алексей Владимирович, Решетняков Дмитрий Валерьевич

    The search for highly effective and safe methods in regenerative medicine has always been and remains an urgent problem. There are many drugs on the pharmacological market, but they cannot be considered to meet the requirements. One of the potential compounds capable of solving this problem is platelet-enriched autoplasm, which is economical and obtained directly from human blood with further centrifugation and platelet activation. An impressive number of studies are presented in the domestic and foreign literature, which confirm its effectiveness in assessing the area of a wound defect, the rate of regeneration and the absence of side effects. This is ensured by the content of a large number of growth factors and various biologically active compounds. In modern surgical practice, platelet-enriched autoplasm has found extensive use in the treatment of chronic wounds of various etiologies, prone to long-term course and frequent relapses; in cosmetology and aesthetic medicine in the issue of improving the appearance of scars; in urology in the treatment of erectile dysfunction; in obstetric and gynecological practice in improving pregnancy and pregnancy outcomes, reducing recurrence of adhesions, correcting functional sexual dysfunction and a favorable course of in vitro fertilization.

  • Open Access

    ADDITIVE NEUROPROTECTIVE EFFECT OF 3-HYDROXYPYRIDINE DERIVATIVES AND HUMAN ERYTHROPOETIN ANALOGUE ON A HEMORRHAGIC STROKE MODEL IN RATS

    by P. D. Kolesnichenko, O. V. Scheblykina, N. I. Nesterova, D. V. Scheblykin, A. V. Nesterov, M. V. Pokrovskiy, M. A. Zhuchenko, A. V. Tverskoy, K. M. Reznikov

    The correction of free radical oxidation processes is one of the most promising strategies of neuroprotection in acute cerebrovascular disorders.The aim of the study is an experimental study of the neuroprotective effects of 3-hydroxypyridine and erythropoietin derivatives, as well as their combined use.Materials and methods. The study was performed on 109 male Wistar rats. The neuroprotective effect of the substances was studied on a hemorrhagic stroke model. The study drugs were administered to the animals intraperitoneally. Carbamylated darbepoetin was administered three times in advance at the dose of 100 µg/kg within intervals of 3 days, the last injection took place 1 hour before the operation (the total dose was 300 mg/kg). Etoxidol was administered once 1 hour before the surgery at the dose of 50 mg/kg. The survival rate, behavioral features and the state of the animals on the 1st, 3rd, 7th and 14th days were recorded, and the morphological assessment of the brain was carried out.Results. The investigated substances had a positive effect on both the survival rate of the animals during the first day and on the 14th day. The best survival rates on the 14th day were recorded in the group of a combined use of ethoxydol and carbamylated darbepoetin (75%). Thus, in this group of rats, a faster recovery of neurological disorders was already distinguished from the first day on. By the 7th day, more than 50% of the rats receiving the combination of the studied drugs, had had a slight neurological deficit (up to 3 points on the McGrow scale); by the 14th day there had been only minor changes in the neurological status in the rats of this group. A pronounced neuroprotective effect of the combination of 3-hydroxypyridine and erythropoietin derivatives has been confirmed by a histological examination of brain slices – a more rapid decrease in the size of perifocal edema and microcirculation disorders, less damage to neurons and glial elements, and faster processes of resorption and organization of hemorrhage. A macroscopic examination of the brain sections stained with triphenyltetrazolium chloride of the dying rats, showed that perifocal necrosis had been the main cause of high mortality in the control group after the 3rd day.Conclusion. As a result of the experiment, the nephroprotective effect of the studied derivatives of 3-hydroxypyridine and erythropoietin has been proved. Moreover, the combination of these drugs has shown a greater neuroprotective activity than their isolated use. The additive effect of these drugs was due to their action mechanism resulting from the synergism of various structures and components of the cells.